Fast Determination of Haloperidol in Pharmaceutical Preparations Using HPLC with a Monolithic Silica Column

Breaking barriers in pharmaceutical analysis: Streamlined UV spectrometric quantification and stability profiling of haloperidol and methylparaben in liquid formulations

This study aims to quantify haloperidol and methylparaben in a liquid pharmaceutical formulation (2 mg/ml) using UV spectrometry and the simultaneous equations method. Additionally, we explored the stability of haloperidol under various stress conditions. The UV analysis revealed maximum absorption peaks at 248 nm for haloperidol and 256 nm for methylparaben, using a 1 % (v/v) lactic acid solution as the solvent. Method validation, conducted according to ICH guidelines, affirmed the method's reliability, showing excellent results in terms of linearity, precision, accuracy, and sensitivity. The method allows direct application to finished products, enabling simultaneous quantification without extractions. Its simplicity, speed, and cost-effectiveness make it ideal for routine controls in pharmaceutical industry haloperidol solution analyses. The method extends to monitoring forced degradation, indicating photolytic and hydrolytic degradation under acidic and basic conditions, while affirming thermal and oxidative stability. This proposed UV spectrometric method serves as a compelling alternative to pharmacopeia-recommended techniques, simplifying simultaneous determination of the active ingredient and preservative. This streamlines analysis, reducing time and costs. Additionally, it proves valuable in small industries lacking sophisticated instrumentation, offering insights into active ingredient behavior during forced degradation.

Cage-like silica nanoparticles-functionalized silica hybrid monolith for high performance capillary electrochromatography via "one-pot" process

A cage-like silica nanoparticles-functionalized silica hybrid monolith for high performance capillary electrochromatography (CEC) has been prepared via "one-pot" process. In this process, the polycondensation of hydrolyzed alkoxysilanes and in situ reaction of mercaptopropyltrimethoxysilane (MPTS) with sodium 3-mercapto-1-propanesulfonate modified octavinyloctasilasesquioxane (MPS-OVS) simultaneously occurred in a pretreated capillary. The characterization and evaluation results indicated that the obtained MPS-OVS hybrid monolithic capillary column has homogeneous macroporous morphology with a permeability of 5.37×10(-13)m(2) and strong electro osmotic flow (EOF) over a wide pH range from 2.7 to 11.2. The EOF on the MPS-OVS hybrid monolithic column reached its maximum of 0.327cm(2)kV(-1)s(-1) at pH 9.7. The best theoretical efficiency of ∼470,000plates/m was obtained for 2-aminophenol in CEC. Anilines and phenols were well separated on the MPS-OVS hybrid monolithic column by CEC, indicating typical reversed-phase and cation-exchange chromatographic retention mechanisms of the column. The monolith was further applied to the separation of bovine serum albumin (BSA) tryptic digests, and the result indicated its potential in the analysis of some complex samples.

High-throughput HPLC assay of acyclovir and its major impurity guanine using a monolithic column and a flow gradient approach

Acyclovir and its major impurity guanine are determined rapidly by the incorporation of a monolithic column (100 mm x 4.6 mm i.d., Merck) to an automated HPLC system. A simple flow gradient protocol was adopted in order to accelerate the separation-detection cycle. Using 0.2% CH(3)COOH (pH 3.1) as the mobile phase and detection at 254 nm, guanine was effectively separated from the system peak (t(R)=1.25 min), while the retention time of acyclovir was 2.35 min. Linearity of the assay was validated in the range 0.1-1.0% guanine and 80-120% acyclovir (n=5). The accuracy and within- and day-to-day precision of the method were also validated, while the limits of detection and quantitation of both analytes were determined. The proposed method was successfully applied to the quality control of acyclovir raw material and the quality and stability control of acyclovir-containing pharmaceutical creams (Hagevir 5%, w/w, Cosmopharm Ltd., Korinthos, Greece).

Quantitative determination of haloperidol in tablets by high performance thin-layer chromatography

A densitometric high performance thin-layer chromatography (HPTLC) method was developed and validated for the quantitative analysis of haloperidol in tablets. Chromatographic separation was achieved on precoated silica gel F 254 HPTLC plates using a mixture of acetone/chloroform/n-butanol/acetic acid glacial/water (5:10:10:2.5:2.5 v/v/v/v/v) as the mobile phase. Quantitative analysis was carried out at a wavelength of 254 nm. The method was linear in the 10-100 ng/microL range, with a determination coefficient of 0.999. The coefficients of variation for precision were not higher than 2.35%. The detection limit was 0.89 ng/microL, and the quantification limit was 2.71 ng/microL. The accuracy ranged from 97.76 to 100.33%, with a CV not higher than 4.50%. This method was successfully applied to quantify haloperidol in real pharmaceutical samples, including the comparison with HPLC measurements. The method was fast, specific, with a good precision and accuracy for the quantitative determination of haloperidol in tablets.